Healthcare Value Capital as of March 31, 2014
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 35 positions in its portfolio as reported in the March 2014 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Spdr S&p 500 Etf (SPY) | 12.2 | $19M | 100k | 187.01 | |
Auxilium Pharmaceuticals | 8.5 | $13M | 480k | 27.18 | |
Ultra Short Russell 2000 | 8.2 | $13M | 275k | 45.88 | |
SPDR S&P MidCap 400 ETF (MDY) | 8.2 | $13M | 50k | 250.58 | |
Teva Pharmaceutical Industries (TEVA) | 7.1 | $11M | 205k | 52.84 | |
Albany Molecular Research | 6.7 | $10M | 548k | 18.59 | |
Baxter International (BAX) | 5.3 | $8.1M | 110k | 73.60 | |
WellCare Health Plans | 5.2 | $7.9M | 125k | 63.52 | |
Health Net | 4.5 | $6.8M | 200k | 34.01 | |
iShares Russell 2000 Index (IWM) | 3.8 | $5.8M | 50k | 116.34 | |
Qlt | 3.0 | $4.6M | 827k | 5.56 | |
Quest Diagnostics Incorporated (DGX) | 2.9 | $4.5M | 77k | 57.92 | |
Merck & Co (MRK) | 2.9 | $4.4M | 77k | 56.77 | |
Biosante Pharmaceuticals (ANIP) | 2.7 | $4.2M | 134k | 31.35 | |
AstraZeneca (AZN) | 2.4 | $3.7M | 57k | 64.89 | |
Pfizer (PFE) | 2.1 | $3.2M | 100k | 32.12 | |
Sanofi-Aventis SA (SNY) | 2.0 | $3.0M | 58k | 52.27 | |
Supernus Pharmaceuticals (SUPN) | 1.8 | $2.7M | 307k | 8.94 | |
Proshares Tr ultsh nasd biot | 1.5 | $2.2M | 125k | 17.82 | |
Ipath S&p 500 Vix S/t Fu Etn | 1.4 | $2.1M | 50k | 42.16 | |
InterMune | 1.1 | $1.7M | 50k | 33.48 | |
Biota Pharmaceuticals | 1.0 | $1.5M | 246k | 6.11 | |
Sorrento Therapeutics (SRNE) | 0.8 | $1.3M | 100k | 12.82 | |
Pharmacyclics | 0.7 | $1.0M | 10k | 100.20 | |
Sunesis Pharmaceuticals | 0.7 | $1.0M | 153k | 6.62 | |
Zogenix | 0.6 | $855k | 300k | 2.85 | |
Rigel Pharmaceuticals | 0.4 | $582k | 150k | 3.88 | |
Galmed Pharmaceuticals | 0.4 | $574k | 50k | 11.48 | |
Fibrocell Science | 0.4 | $564k | 108k | 5.23 | |
Cytokinetics (CYTK) | 0.3 | $538k | 57k | 9.49 | |
Celsion Corporation | 0.3 | $506k | 150k | 3.37 | |
Furiex Pharmaceuticals | 0.3 | $435k | 5.0k | 87.00 | |
Amicus Therapeutics (FOLD) | 0.3 | $414k | 200k | 2.07 | |
AMAG Pharmaceuticals | 0.2 | $387k | 20k | 19.35 | |
D Stemline Therapeutics | 0.2 | $335k | 17k | 20.35 |